Literature DB >> 17932229

Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance.

Biljana Jovov1, Christina M Van Itallie, Nicholas J Shaheen, Johnny L Carson, Todd M Gambling, James M Anderson, Roy C Orlando.   

Abstract

Barrett's esophagus (BE) is a specialized columnar epithelium (SCE) that develops as replacement for damaged squamous epithelium (SqE) in subjects with reflux disease, and as such it is apparently more acid resistant than SqE. How SCE resists acid injury is poorly understood; one means may involve altered tight junctions (TJs) since the TJ in SqE is an early target of attack and damage by acid in reflux disease. To assess this possibility, quantitative RT-PCR for 21 claudins was performed on endoscopic biopsies on SCE of BE and from healthy SqE from subjects without esophageal disease. In SCE, Cldn-18 was the most highly expressed at the mRNA level and this finding is paralleled by marked elevation in protein expression on immunoblots. In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable at the protein level. Immunofluorescence studies showed membrane localization of Cldn-18 and colocalization with the tight junction protein, zonula occludens-1. When Cldn-18 was overexpressed in MDCK II cells and mounted as monolayers in Ussing chambers, it raised electrical resistance and, as shown by lower dilution potentials to a NaCl gradient and lower diffusion potentials to acidic gradients, selectively reduced paracellular permeability to both Na(+) and H(+) compared with parental MDCK cells. We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich TJ in SCE contributes to the greater acid resistance of BE.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932229     DOI: 10.1152/ajpgi.00158.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  56 in total

1.  Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers.

Authors:  Heta Merikallio; Paavo Pääkkö; Terttu Harju; Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2011-09-27

Review 2.  Early events during neoplastic progression in Barrett's esophagus.

Authors:  Brian J Reid
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 3.  Barrett esophagus: an update.

Authors:  Rami J Badreddine; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 46.802

Review 4.  New models of neoplastic progression in Barrett's oesophagus.

Authors:  Kirill Pavlov; Carlo C Maley
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

5.  Claudin-18 is an early-stage marker of pancreatic carcinogenesis.

Authors:  Mariko Tanaka; Junji Shibahara; Noriyoshi Fukushima; Aya Shinozaki; Makoto Umeda; Shumpei Ishikawa; Norihiro Kokudo; Masashi Fukayama
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

6.  New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical management.

Authors:  Brian J Reid; Rumen Kostadinov; Carlo C Maley
Journal:  Clin Cancer Res       Date:  2011-04-15       Impact factor: 12.531

Review 7.  Physiology and function of the tight junction.

Authors:  James M Anderson; Christina M Van Itallie
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

Review 8.  Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation.

Authors:  Vicky Garcia-Hernandez; Miguel Quiros; Asma Nusrat
Journal:  Ann N Y Acad Sci       Date:  2017-05-10       Impact factor: 5.691

9.  Lubiprostone protects esophageal mucosa from acid injury in porcine esophagus.

Authors:  Leandi Krüger; Tiffany A Pridgen; Ellie R Taylor; Katherine S Garman; Anthony T Blikslager
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-02-18       Impact factor: 4.052

10.  Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.

Authors:  Kathy Hormi-Carver; Xi Zhang; Hui Ying Zhang; Robert H Whitehead; Lance S Terada; Stuart J Spechler; Rhonda F Souza
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.